Medindia LOGIN REGISTER
Medindia

Quest to Conquer Antibiotic Resistance With Structural Secrets

by Karishma Abhishek on Jul 2 2023 12:35 AM
Listen to this article
0:00/0:00

Worldwide collaboration yields in-depth structural comprehension of a crucial bacterial enzyme, providing a foundation for chemists to design breakthrough drugs.

Quest to Conquer Antibiotic Resistance With Structural Secrets
Global team, including Trinity College Dublin scientists, obtains a detailed structural understanding of crucial bacterial enzymes, offering opportunities for chemists to develop novel drugs that can inhibit its activity and combat disease-causing bacteria amid increasing concerns about antibiotic resistance (1 Trusted Source
Structure snapshots reveal the mechanism of a bacterial membrane lipoprotein N-acyltransferase

Go to source
).

Unveiling the Battle Plan

The scientists, led by Martin Caffrey, Fellow Emeritus in Trinity’s School of Medicine and School of Biochemistry and Immunology, used next-gen X-ray crystallography and single particle cryo-electron microscopy techniques to “look under the bacterial bonnet” and produce a molecular blueprint of the full-length enzyme that may be used to design drugs that attack any structural weaknesses.
Because the enzyme Lnt is not found in humans – it only exists in bacteria and helps them build stable cell membranes through which things are transported in and out of cells – it is of huge potential significance as a therapeutic target as any bespoke drug designed to attack it should have fewer side-effects for patients.

The research has just been published in the leading international journal Science Advances.

Confronting the Threat Worldwide

Martin Caffrey said: “A number of disease-causing bacteria have developed resistance to a plethora of first-choice drugs used to treat them and, with antimicrobial resistance on the rise in general, the World Health Organization has for some time now advised that a post-antibiotic era, in which minor injuries and common infections could prove fatal, is looming”.

“New drugs are therefore badly needed and, while the journey can be a long one from providing a structural blueprint like this to developing a new drug, the precision to which we have resolved this potential target paints something of a ‘bullseye’ on that target.”

Reference:
  1. Structure snapshots reveal the mechanism of a bacterial membrane lipoprotein N-acyltransferase - (https://www.science.org/doi/10.1126/sciadv.adf5799)

Source-Eurekalert


Advertisement